Drug profile · INN
chloroxine
CAPITROL
chloroxine (CAPITROL) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — chloroxine
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
chloroxine (CAPITROL) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN chloroxine
Brand CAPITROL
Mechanism DNA inhibitor
Target DNA
Route TOPICAL
Formulation SHAMPOO
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is chloroxine?
chloroxine (CAPITROL) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for chloroxine?
CAPITROL is a marketed brand name for chloroxine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chloroxine?
chloroxine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.